Madison Square Garden Q1 2025 GAAP EPS $(0.31) Beats $(0.79) Estimate, Sales $53.307M Beat $43.671M Estimate
Portfolio Pulse from Benzinga Newsdesk
Madison Square Garden (NYSE:MSGS) reported better-than-expected Q1 2025 results with a GAAP EPS of $(0.31), beating the estimate of $(0.79), and sales of $53.307M, surpassing the $43.671M estimate. Sales increased by 23.84% compared to the same period last year.
November 01, 2024 | 11:33 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Madison Square Garden's Q1 2025 results exceeded expectations with a GAAP EPS of $(0.31) and sales of $53.307M, both beating analyst estimates. Sales also grew by 23.84% year-over-year.
The better-than-expected earnings and sales figures are likely to positively impact MSGS's stock price in the short term. The significant beat on both EPS and sales estimates, along with a notable year-over-year sales increase, suggests strong performance and potential investor confidence.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100